title: BEAM-conditioned autologous SCT improves the quality of response in Waldenström's macroglobulinaemia and lymphoplasmacytic lymphoma: a single centre's 10-year experience.
authors.affiliation: Department of Haematology, University College London Hospitals NHS Foundation Trust, London, UK.
authors.forename: M A V
authors.initials: MA
authors.lastname: Marzolini
authors.affiliation: Department of Haematology, University College London Hospitals NHS Foundation Trust, London, UK.
authors.forename: K J
authors.initials: KJ
authors.lastname: Thomson
authors.affiliation: Department of Haematology, University College London Hospitals NHS Foundation Trust, London, UK.
authors.forename: J
authors.initials: J
authors.lastname: Dorman
authors.affiliation: Department of Haematology, University College London Hospitals NHS Foundation Trust, London, UK.
authors.forename: S
authors.initials: S
authors.lastname: D'Sa
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use*; D002330:Carmustine / Q000008:administration & dosage; D003561:Cytarabine / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D005260:Female; D006801:Humans; D008223:Lymphoma / Q000628:therapy*; D008297:Male; D008558:Melphalan / Q000008:administration & dosage; D008875:Middle Aged; D033581:Stem Cell Transplantation / Q000379:methods*; D016019:Survival Analysis; D014182:Transplantation, Autologous / Q000379:methods*; D008258:Waldenstrom Macroglobulinemia / Q000628:therapy*
chemical_list: D003561:Cytarabine; D005047:Etoposide; D008558:Melphalan; D002330:Carmustine